A company will begin clinical trials for a new treatment for liver disease which focuses on growing tiny livers inside the patient's body.
by growing an entirely new liver within the patient. It won’t just rely on one new liver, either. Instead, patients will grow multiple tiny livers in their bodies.Image source: PIC4U / Adobe
The process, which has shown success in mice, pigs, and dogs, involves injecting healthy liver cells into the patient’s lymph nodes. The cells then multiply inside the patient’s body, growing into tiny functioning versions of the larger organ. It’s an intriguing treatment for liver disease, and so far, it has improved liver function in animals that have received the treatment.
The clinical trial focuses on using the lymph nodes in the patients to create bioreactors that can grow the new livers. Not only would this give people dealing with liver disease more options, but it would also relieve pressure on an already overloaded transplant system.These groups will then receive different doses that include 50 million, 150 million, or 250 million cells. The belief right now is that every 50 million cells will allow the patient to grow one mini liver.
On top of the cell injections, though, LyGenesis will also need to provide immune-suppressing drugs to the patients. This will prevent their bodies from reacting badly to the new cells and attacking them. LyGenesis alsoit is collaborating with another company called iTolerance to eliminate the need for immune-suppressing drugs. It’s unclear exactly when that research will allow them to do that, though.
Until then, the participants in the clinical trial for the new liver disease treatment will need to receive the suppressants. From here, it is only a matter of waiting to see how the livers grow or if they even grow within human bodies. Again, if this trial proves successful, it will open up new doors for how we treat liver disease. The trial kicks off soon and will hopefully finish within two years.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Life expectancy in the U.S. dropped in 2021 for the second year in a row, but Covid deaths aren't the only reasonOther contributors to the decline are long-standing problems: drug overdoses, heart disease, suicide and chronic liver disease.
Read more »
US life expectancy plunged again in 2021, down nearly a yearCOVID deaths were blamed for about half the decline in 2021. Some other big contributors include drug overdoses, heart disease, suicide and chronic liver disease.
Read more »
CHP to begin Labor Day maximum enforcement periodThis begins Friday, Sept. 2 through 11:59 p.m. Monday, Sept. 5, according to CHP.
Read more »
US clears updated COVID boosters targeting newest omicron strain; shots could begin within daysFDA clears updated COVID booster vaccines targeting newest omicron variant strain; shots could begin within days
Read more »